Mark Demitrack
Chief Tech/Sci/R&D Officer at TREVENA, INC.
Net worth: 16 882 $ as of 31/03/2024
Profile
Mark A.
Demitrack currently works at Trevena, Inc., as Chief Medical Officer & Senior Vice President from 2018 and American College of Neuropsychopharmacology, as Member.
Dr. Demitrack also formerly worked at Lilly Research Laboratories, as Medical Director-New Antidepressant Team, Neuronetics, Inc., as Chief Medical Officer & Vice President from 2003 to 2017, Roivant Sciences Ltd., as Vice President-Clinical Strategy from 2017 to 2018, and Wyeth Pharmaceuticals, Inc., as Assistant Vice President-Global Medical Affairs.
Dr. Demitrack received his undergraduate degree from The Trustees of Columbia University in The City of New York and doctorate degree from Robert Wood Johnson Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TREVENA, INC.
0.20% | 09/02/2024 | 36,700 ( 0.20% ) | 16 882 $ | 31/03/2024 |
Mark Demitrack active positions
| Companies | Position | Start |
|---|---|---|
| TREVENA, INC. | Chief Tech/Sci/R&D Officer | 21/05/2018 |
American College of Neuropsychopharmacology
 American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Corporate Officer/Principal | - |
Former positions of Mark Demitrack
| Companies | Position | End |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01/05/2018 |
| NEURONETICS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2017 |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Corporate Officer/Principal | - |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Corporate Officer/Principal | - |
Training of Mark Demitrack
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Robert Wood Johnson Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| NEURONETICS, INC. | Health Technology |
| ROIVANT SCIENCES LTD. | Health Technology |
| TREVENA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
American College of Neuropsychopharmacology
American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Commercial Services |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
- Stock Market
- Insiders
- Mark Demitrack
